Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 6 (2009), Issue 6 (June)

1. Early-onset psychoses: comparison of clinical features and adult outcome in 3 diagnostic groups.
   Child Psychiatry Hum Dev, 40(3): 421-37. [Abstract] [Full-text]
2. Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses.
   Biol Psychiatry, 65(12): 1055-62. [Abstract] [Full-text]
3. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior.
   J Pharmacol Toxicol Methods, 59(3): 141-5. [Abstract] [Full-text]
4. The Mood Disorder Burden Index: a scale for assessing the burden of caregivers to adults with unipolar or bipolar disorder.
   Psychiatry Res, 168(1): 67-77. [Abstract] [Full-text]
5. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
   Eur Neuropsychopharmacol, 19(7): 520-32. [Abstract] [Full-text]
6. Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis.
   Psychiatry Res, 173(1): 77-82. [Abstract] [Full-text]
7. Reduced brain activation in euthymic bipolar patients during response inhibition: an event-related fMRI study.
   Psychiatry Res, 173(1): 45-51. [Abstract] [Full-text]
8. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
   J Psychopharmacol. [Abstract] [Full-text]
9. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders.
   J Med Genet, 46(6): 382-8. [Abstract] [Full-text]
10. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.
    Am J Psychiatry, 166(6): 718-25. [Abstract] [Full-text]
11. Prevalence of serious mental illness among jail inmates.
    Psychiatr Serv, 60(6): 761-5. [Abstract] [Full-text]
12. Sexual problems in a sample of the Turkish psychiatric population.
    Compr Psychiatry, 50(4): 353-60. [Abstract] [Full-text]
13. The duration of inpatient admission predicts cognitive functioning at discharge in patients with bipolar disorder.
    Compr Psychiatry, 50(4): 322-6. [Abstract] [Full-text]
14. How common are psychotic and bipolar disorders? A 50-year follow-up of the Lundby population.
    Nord J Psychiatry. [Abstract] [Full-text]
15. Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.
    Postgrad Med, 121(3): 73-82. [Abstract] [Full-text]
16. Bipolar disorder and aggression.
    Int J Clin Pract, 63(6): 889-99. [Abstract] [Full-text]
17. Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder.
    J ECT, 25(2): 137-40. [Abstract] [Full-text]
18. When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR(*)D Study.
    Neuropsychopharmacology. [Abstract] [Full-text]
19. Glutamate-mediated calcium signaling: a potential target for lithium action.
    Neuroscience, 161(4): 1126-34. [Abstract] [Full-text]
20. Neuropsychiatric disorders: Shared genetics of bipolar disorder and schizophrenia.
    Nat Rev Neurol, 5(6): 299-300. [Abstract] [Full-text]
21. Treatment nonadherence and neurocognitive impairment in bipolar disorder.
    J Clin Psychiatry. [Abstract] [Full-text]
22. A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders.
    Bipolar Disord, 11(4): 425-33. [Abstract] [Full-text]
23. Earliest symptoms discriminating juvenile-onset bipolar illness from ADHD.
    Bipolar Disord, 11(4): 441-51. [Abstract] [Full-text]
24. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response.
    Bipolar Disord, 11(4): 418-24. [Abstract] [Full-text]
25. A longitudinal study of hypomania and depression symptoms in pregnancy and the postpartum period.
    Bipolar Disord, 11(4): 410-7. [Abstract] [Full-text]
26. Clinical predictors of functional outcome of bipolar patients in remission.
    Bipolar Disord, 11(4): 401-9. [Abstract] [Full-text]
27. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
    Bipolar Disord, 11(4): 391-400. [Abstract] [Full-text]
28. Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study.
    Bipolar Disord, 11(4): 382-90. [Abstract] [Full-text]
29. MEG auditory evoked fields suggest altered structural/functional asymmetry in primary but not secondary auditory cortex in bipolar disorder.
    Bipolar Disord, 11(4): 371-81. [Abstract] [Full-text]
30. Cortical folding difference between patients with early-onset and patients with intermediate-onset bipolar disorder.
    Bipolar Disord, 11(4): 361-70. [Abstract] [Full-text]
31. Fronto-temporal dysregulation in remitted bipolar patients: an fMRI delayed-non-match-to-sample (DNMS) study.
    Bipolar Disord, 11(4): 351-60. [Abstract] [Full-text]
32. Frequency of subsyndromal symptoms and employment status in patients with bipolar disorder.
    Soc Psychiatry Psychiatr Epidemiol, 44(7): 515-22. [Abstract] [Full-text]
33. FYN kinase gene: another glutamatergic gene associated with bipolar disorder?
    Neuropsychobiology, 59(3): 178-83. [Abstract] [Full-text]
34. A review of the safety and tolerability of aripiprazole.
    Expert Opin Drug Saf, 8(3): 373-86. [Abstract] [Full-text]
35. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
    Int J Neuropsychopharmacol, 12(6): 773-82. [Abstract] [Full-text]
36. Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.
    Int J Neuropsychopharmacol, 12(6): 851-60. [Abstract] [Full-text]
37. Disability and self-management practices of people with bipolar disorder: a web-based survey.
    Community Ment Health J, 45(3): 179-87. [Abstract] [Full-text]
38. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
    Acta Psychiatr Scand, 120(1): 10-3. [Abstract] [Full-text]
39. Atypical depression is associated with suicide attempt in bipolar disorder.
    Acta Psychiatr Scand, 120(1): 30-6. [Abstract] [Full-text]
40. Analysis of a Promoter Polymorphism in the SMDF Neuregulin 1 Isoform in Schizophrenia.
    Neuropsychobiology, 59(4): 205-212. [Abstract] [Full-text]
41. Rages--what are they and who has them?
    J Child Adolesc Psychopharmacol, 19(3): 281-8. [Abstract] [Full-text]
42. Co-morbid disorders and sexual risk behavior in Nigerian adolescents with bipolar disorder.
    Int Arch Med, 2(1): 16. [Abstract] [Full-text]
43. The promotion of olanzapine in primary care: an examination of internal industry documents.
    Soc Sci Med, 69(1): 14-20. [Abstract] [Full-text]
44. Nonverbal social behaviors of patients with bipolar mania during interactions with virtual humans.
    J Nerv Ment Dis, 197(6): 412-8. [Abstract] [Full-text]
45. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?
    Schizophr Bull, 35(4): 748-59. [Abstract] [Full-text]
46. Genetic and disorder-specific aspects of resting state EEG abnormalities in schizophrenia.
    Schizophr Bull, 35(4): 826-39. [Abstract] [Full-text]
47. Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials.
    J Psychopharmacol, 23(5): 574-591. [Abstract] [Full-text]
48. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Neuropsychopharmacology, 34(8): 1904-13. [Abstract] [Full-text]
49. Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity.
    Mol Cell Neurosci, 41(3): 373-82. [Abstract] [Full-text]
50. Effects of lithium chloride on the gene expression profiles in Drosophila heads.
    Neurosci Res, 64(4): 413-20. [Abstract] [Full-text]
51. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
    Arthritis Rheum, 61(6): 822-9. [Abstract] [Full-text]
52. Association of vaginal bleeding and electroconvulsive therapy use in pregnancy.
    J Obstet Gynaecol Res, 35(3): 569-71. [Abstract] [Full-text]
53. Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins.
    Am J Med Genet B Neuropsychiatr Genet, 150(5): 683-92. [Abstract] [Full-text]
54. Genome scan in sibling pairs with juvenile-onset mood disorders: Evidence for linkage to 13q and Xq.
    Am J Med Genet B Neuropsychiatr Genet, 150(5): 638-46. [Abstract] [Full-text]
55. Bipolar disorder in the elderly; different effects of age and of age of onset.
    J Affect Disord, 116(3): 176-83. [Abstract] [Full-text]
56. Family-based association study of Neuregulin 1 with psychotic bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 150(5): 693-702. [Abstract] [Full-text]
57. Comparison of sleep/wake parameters for self-monitoring bipolar disorder.
    J Affect Disord, 116(3): 170-5. [Abstract] [Full-text]
58. Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.
    J Affect Disord, 116(3): 184-91. [Abstract] [Full-text]
59. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS.
    J Affect Disord, 116(3): 222-6. [Abstract] [Full-text]
60. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.
    J Affect Disord, 116(3): 214-7. [Abstract] [Full-text]
61. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis.
    Schizophr Res, 112(1): 72-9. [Abstract] [Full-text]
62. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.
    Schizophr Res, 112(1): 54-64. [Abstract] [Full-text]
63. Is depersonalization disorder initiated by illicit drug use any different? a survey of 394 adults.
    J Clin Psychiatry. [Abstract] [Full-text]
64. Identifying and treating cognitive impairment in bipolar disorder.
    Bipolar Disord, 11: 123-37. [Abstract] [Full-text]
65. Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions.
    Bipolar Disord, 11: 110-22. [Abstract] [Full-text]
66. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.
    Bipolar Disord, 11: 92-109. [Abstract] [Full-text]
67. Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium.
    Bipolar Disord, 11: 84-91. [Abstract] [Full-text]
68. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice.
    Bipolar Disord, 11: 77-83. [Abstract] [Full-text]
69. Medicating mood with maintenance in mind: bipolar depression pharmacotherapy.
    Bipolar Disord, 11: 55-76. [Abstract] [Full-text]
70. Lithium specificity in bipolar illness: a classic agent for the classic disorder.
    Bipolar Disord, 11: 34-44. [Abstract] [Full-text]
71. Anticonvulsants in bipolar disorders: current research and practice and future directions.
    Bipolar Disord, 11: 20-33. [Abstract] [Full-text]
72. A critical appraisal of lithium's efficacy and effectiveness: the last 60 years.
    Bipolar Disord, 11: 10-9. [Abstract] [Full-text]
73. What happens after diagnosis? Understanding the experiences of patients with newly-diagnosed bipolar disorder.
    Health Expect, 12(2): 120-9. [Abstract] [Full-text]
74. The development of the serious mental illness physical Health Improvement Profile.
    J Psychiatr Ment Health Nurs, 16(5): 493-8. [Abstract] [Full-text]
75. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol.
    Mol Psychiatry, 14(7): 696-704, 647. [Abstract] [Full-text]
76. Testing random effects in the linear mixed model using approximate bayes factors.
    Biometrics, 65(2): 369-76. [Abstract] [Full-text]
77. Irritability without elation in a large bipolar youth sample: frequency and clinical description.
    J Am Acad Child Adolesc Psychiatry, 48(7): 730-9. [Abstract] [Full-text]
78. Hypersomnia across mood disorders: a review and synthesis.
    Sleep Med Rev, 13(4): 275-85. [Abstract] [Full-text]
79. Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication.
    BMC Psychiatry, 9: 33. [Abstract] [Full-text]
80. Social support and unsolicited advice in a bipolar disorder online forum.
    Qual Health Res, 19(7): 931-42. [Abstract] [Full-text]
81. Aripiprazole-induced hiccups: a case report.
    Gen Hosp Psychiatry, 31(4): 382-4. [Abstract] [Full-text]
82. Seizure (Ictal)-EEG Characteristics in Subgroups of Depressive Disorder in Patients Receiving Electroconvulsive Therapy (ECT)-A Preliminary Study and Multivariate Approach.
    Comput Intell Neurosci, 2009: 965209. [Abstract] [Full-text]
83. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    J Med Econ. [Abstract] [Full-text]
84. alpha/beta-Arteether-induced mania in a predisposed adolescent.
    Gen Hosp Psychiatry, 31(4): 391-3. [Abstract] [Full-text]
85. Detection of stable reference genes for real-time PCR analysis in schizophrenia and bipolar disorder.
    Anal Biochem, 391(2): 91-7. [Abstract] [Full-text]
86. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease.
    Proteomics, 9(12): 3368-3382. [Abstract] [Full-text]
87. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
    Pharmacotherapy, 29(7): 852-7. [Abstract] [Full-text]
88. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.
    J Psychiatr Res, 43(11): 970-7. [Abstract] [Full-text]
89. Trends in mental health admissions to nursing homes, 1999-2005.
    Psychiatr Serv, 60(7): 965-71. [Abstract] [Full-text]
90. Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients.
    Psychiatr Serv, 60(7): 888-97. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.